Orla Mining has shed 14.5% in a week — nearly double the drawdown of its closest gold peers — yet the most recent institutional filing shows Hamblin Watsa added more than 24 million shares, a tension that defines the setup heading into July results.
The underperformance against peers is the first thing worth unpacking. Close sector correlates EQX and IMG dropped 14.2% and 9.3% respectively on the week. AEM and CG fell 8.9% and 7.7%. OLA's 14.5% decline is an outlier even in a bad week for gold. The stock now trades at CAD 13.89, down 16% on the month, sitting at roughly half its 52-week high. The prior stock-score note flagged that ratio — the stock was at 100% of its 52-week high at year-end 2025; it has nearly halved since.
The short-selling picture offers little by way of explanation for the extra weakness. Short interest is barely 0.6% of the free float — not a meaningful bearish position by any measure. The most notable feature of the SI history is a structural drop: short positions ran around 3.8 million shares through late May before collapsing to under 2 million in early June, a ~50% reduction over 30 days, and have held near those lower levels since. Borrow costs have also eased sharply, falling nearly 49% on the week to 0.57% annualised. Availability is extraordinarily loose — there are roughly 52 shares available to lend for every one currently borrowed, putting the borrow market firmly in "no constraint" territory. Whatever is driving the selloff, it is not a short-driven event.
The institutional ownership story is where things get genuinely interesting. Hamblin Watsa Investment Counsel — the investment arm of Fairfax Financial — reported adding 24.8 million shares as recently as June 8, bringing its stake to 56.6 million shares, or 16.4% of the company. That makes it the largest single institutional holder by a meaningful margin, ahead of Newmont at 12.5% and Fidelity (FMR) at 9.3%. Pierre Lassonde, the royalty industry veteran, also added 2.5 million shares in the same filing, holding 9.2% of the company. These are not passive index buyers drifting in — they are active, high-conviction holders who added meaningfully at prices above where the stock trades today. The net insider picture over the past 90 days is marginally positive by value (net ~$1.3 million), though the CFO sold 15,600 shares in late May at prices near CAD 17, well above the current level.
The analyst read is constructive but thinly covered. Three buy-rated analysts hold a mean price target around CAD 22.79 — implying roughly 64% upside from the current price. No recent target changes appear in the data, so those targets were set at prices materially above today's. The factor-score picture is mixed: the short-score rank is elevated at the 86th percentile, reflecting that short-side pressure relative to the broader universe is above average even if absolute levels are low. EPS momentum scores are weak, ranking in the 11th–18th percentile on both 30- and 90-day windows, and the EPS surprise rank is just 24th percentile. The PE multiple has compressed to around 6.3x and EV/EBITDA to roughly 3.0x — low even by mid-tier gold producer standards, consistent with the market applying a discount for the recent operational or macro concerns weighing on the stock.
Earnings arrive July 31. The two most recent post-result moves logged in the data are a near-flat one-day reaction in June followed by a 11% five-day drift lower, and a 3.7% drop on the day in May with an 18.8% five-day decline. The five-day pattern after both recent prints was consistently negative. With the stock already down sharply from its highs and institutional holders sitting on unrealised losses, how management frames Camino Rojo production and cost guidance on that July call will likely determine whether the current discount begins to close or widens further.
See the live data behind this article on ORTEX.
Open OLA on ORTEX →ORTEX Market Intelligence content is generated by AI from a snapshot of ORTEX's proprietary data. Content is informational only and does not constitute investment advice.